witnessing the start of a 5 to Disallowed., page-272

Just thinking 'what if all the little ducks lined up in a row'. Little ducks include (and all expected-except item b which is a possibility- prior to Xmas).
A. Anti cancer research report
B. Tie in partner
C. Results on clinical trials

In my pondering, I question why, when alt103 has an early end point and the trials were completed approx 3 weeks ago that we would not expect the results of research study any day now.

Furthermore, I would suggest the professor would be in a position to share the findings of his report with ANP prior to submission. If I were commissioned as a consultant, I know I would be bound to consult with my client as reports / data is established.

Is this why ANP are so confident?.

OR, by the fact this wasn't given much notable attention in ANP investor presentation should we reasonably presume report won't be that fantastic.?

Would like to hear of your hypothesis.

P.s this is strictly IMO